Growth Factors of Multiple Myeloma Market
Multiple myeloma (MM) is a rare yet significant form of blood cancer, accounting for a notable number of cancer cases worldwide. The global multiple myeloma market was valued at USD 19.48 billion in 2018 and is projected treach USD 31.00 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.0% during the forecast period.
Key Market Drivers
1. Increasing Prevalence of Multiple Myeloma: The rising incidence of MM globally has heightened the demand for effective and advanced therapeutics. Early diagnosis and treatment are crucial, as untreated MM can lead tfatal outcomes. The growing awareness of disease symptoms has contributed thigher diagnosis rates, thereby expanding the patient pool requiring treatment.
2. Advancements in Drug Development: Significant investments in research and development have led tthe introduction of several blockbuster drugs, enhancing treatment options for MM patients. The focus on novel therapies aims timprove patient outcomes and address unmet clinical needs. For instance, the development of bispecific antibodies like REGN5458 has shown promising results in clinical trials.
3. Robust Pipeline of Therapeutics: Pharmaceutical companies are actively engaged in developing new treatments for MM, with numerous clinical trials underway. The strong pipeline reflects the commitment tintroducing innovative therapies that can offer better efficacy and safety profiles. The anticipated introduction of more advanced therapeutics is expected tfuel market growth.
Market Segmentation
The multiple myeloma market is segmented based on drug class and distribution channel:
- By Drug Class:
Proteasome Inhibitors
Anti-CD38 Monoclonal Antibodies
Alkylating Agents
Others
- By Distribution Channel:
Retail Pharmacies & Drug Stores
Online Pharmacies
Among these, the immunomodulators segment is expected tlead the market during the forecast period, driven by their efficacy in treatment protocols.
Regional Insights
North America dominated the multiple myeloma market in 2018, attributed tthe high prevalence of the disease, advanced healthcare infrastructure, and significant investment in research and development. The region's proactive approach tadopting new therapies has alscontributed tits leading position.
Europe holds the second-largest market share, supported by increasing awareness and availability of advanced treatments. The Asia-Pacific region is anticipated texhibit the highest growth rate during the forecast period, owing tthe rising healthcare expenditure, improving healthcare infrastructure, and growing awareness about multiple myeloma.
Competitive Landscape
The multiple myeloma market is characterized by the presence of several key players focusing on expanding their product portfolios and geographical reach. Some of the leading companies include:
- CELGENE CORPORATION (Bristol Myers Squibb Company)
- Amgen Inc.
- Janssen Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Sanofi
- AbbVie Inc.
- Karyopharm Therapeutics
Future Outlook
The multiple myeloma market is poised for significant growth, driven by the increasing prevalence of the disease, advancements in therapeutic options, and a strong pipeline of novel treatments. The anticipated introduction of more advanced therapeutics, coupled with increased awareness and early diagnosis, is expected tfuel the demand for multiple myeloma treatment products.
Moreover, the expansion of distribution channels, including online pharmacies, is likely tenhance accessibility ttreatments, further propelling market growth. As research continues tevolve, the focus remains on developing therapies that offer improved efficacy, safety, and quality of life for patients battling multiple myeloma.
In conclusion, the multiple myeloma market is undergoing transformative growth, underpinned by scientific advancements and a concerted effort taddress the challenges associated with this complex disease. The collaborative endeavors of pharmaceutical companies, research institutions, and healthcare providers are pivotal in shaping a promising future for multiple myeloma treatment and management.
ATTRIBUTE DETAILS
Study Period - 2015-2026
Base Year - 2018
Forecast Period - 2019-2026
Historical Period - 2015-2017
Unit - Value (USD billion)
Segmentation By Drug Class
- Immunomodulators
- Proteasome Inhibitor
- Anti-CD38 Monoclonal Antibody
- Alkylating Agents
- Others
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)
- Latin America (Brazil, Mexico, and the Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Venous Leg Ulcer, DVT, Lymphedema and other key indications by country/region
- 4.2. Key Industry Trends
- 4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
- 4.4. New Product Launches
- 5. Global Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Compression Garments
- 5.2.1.1. Compression Bandages
- 5.2.1.2. Compression Stockings
- 5.2.1.3. Others
- 5.2.2. Compression Pumps
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Venous Leg Ulcer
- 5.3.2. Deep Vein Thrombosis
- 5.3.3. Lymphedema
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals & Clinics
- 5.4.2. Nursing Care Centers
- 5.4.3. Home Care
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Country
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Product
- 6.2.1. Compression Garments
- 6.2.1.1. Compression Bandages
- 6.2.1.2. Compression Stockings
- 6.2.1.3. Others
- 6.2.2. Compression Pumps
- 6.2.3. Others
- 6.3. Market Analysis – By Application
- 6.3.1. Venous Leg Ulcer
- 6.3.2. Deep Vein Thrombosis
- 6.3.3. Lymphedema
- 6.3.4. Others
- 6.4. Market Analysis – By End User
- 6.4.1. Hospitals & Clinics
- 6.4.2. Nursing Care Centers
- 6.4.3. Home Care
- 6.4.4. Others
- 6.5. Market Analysis – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Product
- 7.2.1. Compression Garments
- 7.2.1.1. Compression Bandages
- 7.2.1.2. Compression Stockings
- 7.2.1.3. Others
- 7.2.2. Compression Pumps
- 7.2.3. Others
- 7.3. Market Analysis – By Application
- 7.3.1. Venous Leg Ulcer
- 7.3.2. Deep Vein Thrombosis
- 7.3.3. Lymphedema
- 7.3.4. Others
- 7.4. Market Analysis – By End User
- 7.4.1. Hospitals & Clinics
- 7.4.2. Nursing Care Centers
- 7.4.3. Home Care
- 7.4.4. Others
- 7.5. Market Analysis – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Product
- 8.2.1. Compression Garments
- 8.2.1.1. Compression Bandages
- 8.2.1.2. Compression Stockings
- 8.2.1.3. Others
- 8.2.2. Compression Pumps
- 8.2.3. Others
- 8.3. Market Analysis – By Application
- 8.3.1. Venous Leg Ulcer
- 8.3.2. Deep Vein Thrombosis
- 8.3.3. Lymphedema
- 8.3.4. Others
- 8.4. Market Analysis – By End User
- 8.4.1. Hospitals & Clinics
- 8.4.2. Nursing Care Centers
- 8.4.3. Home Care
- 8.4.4. Others
- 8.5. Market Analysis – By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Product
- 9.2.1. Compression Garments
- 9.2.1.1. Compression Bandages
- 9.2.1.2. Compression Stockings
- 9.2.1.3. Others
- 9.2.2. Compression Pumps
- 9.2.3. Others
- 9.3. Market Analysis – By Application
- 9.3.1. Venous Leg Ulcer
- 9.3.2. Deep Vein Thrombosis
- 9.3.3. Lymphedema
- 9.3.4. Others
- 9.4. Market Analysis – By End User
- 9.4.1. Hospitals & Clinics
- 9.4.2. Nursing Care Centers
- 9.4.3. Home Care
- 9.4.4. Others
- 9.5. Market Analysis – By Country
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Product
- 10.2.1. Compression Garments
- 10.2.1.1. Compression Bandages
- 10.2.1.2. Compression Stockings
- 10.2.1.3. Others
- 10.2.2. Compression Pumps
- 10.3. Others
- 10.4. Market Analysis – By Application
- 10.4.1. Venous Leg Ulcer
- 10.4.2. Deep Vein Thrombosis
- 10.4.3. Lymphedema
- 10.4.4. Others
- 10.5. Market Analysis – By End User
- 10.5.1. Hospitals & Clinics
- 10.5.2. Nursing Care Centers
- 10.5.3. Home Care
- 10.5.4. Others
- 10.6. Market Analysis – By Country/Sub-region
- 10.6.1. GCC Countries
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.5.1. SIGVARIS
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. 3M
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. Arjo
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. PAUL HARTMANN Pty. Ltd
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. medi GmbH & Co. KG
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. Essity Aktiebolag (publ)
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. Smith & Nephew
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Bio Compression Systems, Inc.
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. Tactile Systems Technology, Inc.
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 11.5.10. Other Players
- 11.5.10.1. Overview,
- 11.5.10.2. Products & services,
- 11.5.10.3. SWOT analysis,
- 11.5.10.4. Recent developments,
- 11.5.10.5. strategies,
- 11.5.10.6. financials (based on availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook